Document is current
Any future updates will be listed below
-
Authors
Wang, Zi-Xian
Chen, Fan
He, Ming-Ming
Wu, Hao-Xiang
Qian, Zheng-Yu
Pan, Yi-Qian
Chen, Yan-Xing
Xu, Rui-Hua
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82473362)
National Natural Science Foundation of China (82321003, 82173128)
Natural Science Foundation of Guangdong Province (2024A1515012980, 2025B1515020081)
Young Elite Scientists Sponsorship Program by CAST (2023QNRC001)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0501600)
Cancer Innovative Research Program of Sun Yat-sen University Cancer Center (CIRP-SYSUCC-0004)
Sun Yat-sen University Clinical Research 5010 Program (84000-31630002)
- License Information
-
More Information
Article History
Received: 25 November 2025
Revised: 5 January 2026
Accepted: 8 January 2026
First Online: 20 February 2026
Declarations
:
: Not Applicable.
: Not Applicable.
: The corresponding author Rui-Hua Xu reported participating on advisory board for Astellas, MSD, AstraZeneca, Junshi, Hengrui, BeiGene, Innovent, Hutchison, Junshi, Qilu, CPPC, and Keymed. The authors declare no other competing interests.
